The IL13α 2R paves the way for anti-glioma nanotherapy

Glioblastoma (GBM) is one of the most aggressive (grade IV) gliomas characterized by a high rate of recurrence, resistance to therapy and a grim survival prognosis. The long-awaited improvement in GBM patients’ survival rates essentially depends on advances in the development of new therapeutic appr...

Полное описание

Библиографические подробности

Главные авторы:	Ilya V. Ulasov, Anton Borovjagin, Anastasia Laevskaya, Margarita Kamynina, Peter Timashev, Laura Cerchia, Elena A. Rozhkova
Формат:	Artigo
Язык:	Inglês
Опубликовано:	KeAi Communications Co., Ltd. 2023-01-01
Серии:	Genes and Diseases
Предметы:	Brain tumor Experimental therapy GBM IL-13Rα2 Nanoparticles Receptor
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2352304221001033
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!